mixed salts of a single entity amphetamine product xr
Generic: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Labeler: specgx llcDrug Facts
Product Profile
Brand Name
mixed salts of a single entity amphetamine product xr
Generic Name
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
Labeler
specgx llc
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
amphetamine aspartate monohydrate 6.25 mg/1, amphetamine sulfate 6.25 mg/1, dextroamphetamine saccharate 6.25 mg/1, dextroamphetamine sulfate 6.25 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0406-8955
Product ID
0406-8955_d35f2f82-b0de-4f2a-a740-3d95c364cd7b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211547
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2019-04-22
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04068955
Hyphenated Format
0406-8955
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
mixed salts of a single entity amphetamine product xr (source: ndc)
Generic Name
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate (source: ndc)
Application Number
ANDA211547 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 6.25 mg/1
Packaging
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8955-01)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d35f2f82-b0de-4f2a-a740-3d95c364cd7b", "openfda": {"upc": ["0304068956010", "0304068955013"], "unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_set_id": ["60a2834c-38a2-480e-b89c-563e9cf0c9c3"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8955-01)", "package_ndc": "0406-8955-01", "marketing_start_date": "20190422"}], "brand_name": "Mixed Salts of a Single Entity Amphetamine Product XR", "product_id": "0406-8955_d35f2f82-b0de-4f2a-a740-3d95c364cd7b", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0406-8955", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mixed Salts of a Single Entity Amphetamine Product", "brand_name_suffix": "XR", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "6.25 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "6.25 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "6.25 mg/1"}], "application_number": "ANDA211547", "marketing_category": "ANDA", "marketing_start_date": "20190422", "listing_expiration_date": "20261231"}